Stock Scorecard
Stock Summary for Outset Medical Inc (OM) - $20.90 as of 7/4/2025 1:49:59 AM EST
Total Score
7 out of 30
Safety Score
29 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for OM
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for OM
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for OM
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for OM
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for OM (29 out of 100)
Stock Price Rating (Max of 10) | 7 |
Historical Stock Price Rating (Max of 10) | 10 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 4 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 3 |
Analyst Strong Buy Ratings (Max of 5) | 0 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 4 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for OM
Financial Details for OM
Company Overview |
|
---|---|
Ticker | OM |
Company Name | Outset Medical Inc |
Country | USA |
Description | Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. The company is headquartered in San Jose, California. |
Sector Name | LIFE SCIENCES |
Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Most Recent Quarter | 3/31/2025 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 20.90 |
Price 4 Years Ago | 691.35 |
Last Day Price Updated | 7/4/2025 1:49:59 AM EST |
Last Day Volume | 117,376 |
Average Daily Volume | 431,184 |
52-Week High | 72.60 |
52-Week Low | 5.85 |
Last Price to 52 Week Low | 257.26% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 21.59 |
Sector PE | 40.90 |
5-Year Average PE | -78.49 |
Free Cash Flow Ratio | 4.88 |
Industry Free Cash Flow Ratio | 16.63 |
Sector Free Cash Flow Ratio | 32.91 |
Current Ratio Most Recent Quarter | 8.37 |
Total Cash Per Share | 4.28 |
Book Value Per Share Most Recent Quarter | 9.37 |
Price to Book Ratio | 2.20 |
Industry Price to Book Ratio | 3.51 |
Sector Price to Book Ratio | 30.76 |
Price to Sales Ratio Twelve Trailing Months | 3.16 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.47 |
Sector Price to Sales Ratio Twelve Trailing Months | 35.60 |
Analyst Buy Ratings | 3 |
Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
Total Shares Outstanding | 17,722,300 |
Market Capitalization | 370,396,070 |
Institutional Ownership | 83.27% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 25.94% |
Reported EPS 12 Trailing Months | -28.79 |
Reported EPS Past Year | -3.24 |
Reported EPS Prior Year | -1.80 |
Net Income Twelve Trailing Months | -113,815,000 |
Net Income Past Year | -127,976,000 |
Net Income Prior Year | -172,797,000 |
Quarterly Revenue Growth YOY | 5.60% |
5-Year Revenue Growth | 49.79% |
Operating Margin Twelve Trailing Months | -54.90% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 75,928,000 |
Total Cash Past Year | 124,014,000 |
Total Cash Prior Year | 68,509,000 |
Net Cash Position Most Recent Quarter | -18,187,000 |
Net Cash Position Past Year | -73,361,000 |
Long Term Debt Past Year | 197,375,000 |
Long Term Debt Prior Year | 130,113,000 |
Total Debt Most Recent Quarter | 94,115,000 |
Equity to Debt Ratio Past Year | 0.12 |
Equity to Debt Ratio Most Recent Quarter | 0.64 |
Total Stockholder Equity Past Year | 26,819,000 |
Total Stockholder Equity Prior Year | 122,886,000 |
Total Stockholder Equity Most Recent Quarter | 169,868,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -96,735,000 |
Free Cash Flow Per Share Twelve Trailing Months | -5.46 |
Free Cash Flow Past Year | -117,215,000 |
Free Cash Flow Prior Year | -134,813,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.72 |
MACD Signal | 1.04 |
20-Day Bollinger Lower Band | 6.01 |
20-Day Bollinger Middle Band | 14.18 |
20-Day Bollinger Upper Band | 22.35 |
Beta | 2.14 |
RSI | 55.77 |
50-Day SMA | 16.43 |
150-Day SMA | 138.61 |
200-Day SMA | 245.76 |
System |
|
Modified | 7/3/2025 7:00:26 AM EST |